Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Notch1 haploinsufficiency causes ascending aortic aneurysms in mice
Sara N. Koenig, Stephanie LaHaye, James D. Feller, Patrick Rowland, Kan N. Hor, Aaron J. Trask, Paul M.L. Janssen, Freddy Radtke, Brenda Lilly, Vidu Garg
Sara N. Koenig, Stephanie LaHaye, James D. Feller, Patrick Rowland, Kan N. Hor, Aaron J. Trask, Paul M.L. Janssen, Freddy Radtke, Brenda Lilly, Vidu Garg
View: Text | PDF
Research Article Cardiology

Notch1 haploinsufficiency causes ascending aortic aneurysms in mice

  • Text
  • PDF
Abstract

An ascending aortic aneurysm (AscAA) is a life-threatening disease whose molecular basis is poorly understood. Mutations in NOTCH1 have been linked to bicuspid aortic valve (BAV), which is associated with AscAA. Here, we describe a potentially novel role for Notch1 in AscAA. We found that Notch1 haploinsufficiency exacerbated the aneurysmal aortic root dilation seen in the Marfan syndrome mouse model and that heterozygous deletion of Notch1 in the second heart field (SHF) lineage recapitulated this exacerbated phenotype. Additionally, Notch1+/– mice in a predominantly 129S6 background develop aortic root dilation, indicating that loss of Notch1 is sufficient to cause AscAA. RNA sequencing analysis of the Notch1.129S6+/– aortic root demonstrated gene expression changes consistent with AscAA. These findings are the first to our knowledge to demonstrate an SHF lineage–specific role for Notch1 in AscAA and suggest that genes linked to the development of BAV may also contribute to the associated aortopathy.

Authors

Sara N. Koenig, Stephanie LaHaye, James D. Feller, Patrick Rowland, Kan N. Hor, Aaron J. Trask, Paul M.L. Janssen, Freddy Radtke, Brenda Lilly, Vidu Garg

×

Figure 5

RNA sequencing reveals gene expression changes in Notch1.129S6+/– aortic root.

Options: View larger image (or click on image) Download as PowerPoint
RNA sequencing reveals gene expression changes in Notch1.129S6+/– aortic...
(A) Diagram showing 1 mm section of proximal (aortic root) and distal ascending aorta from 2-month-old mice that was used for RNA-seq (n = 3/group). (B) Summary of differentially expressed genes that were identified with a fold change of ± 1.5 and determined to have a P < 0.05 by Tukey test. (C) Heatmap generated with the log2-transformed RPKM values of the 522 ANOVA P < 0.05. Hierarchical clustering indicates samples associate strongest by location. (D) Volcano plot representing the differential gene expression between Notch1.129S+/– vs. WT proximal aortas. Gray points are not significantly differentially expressed. Green points represent genes with a P < 0.05, blue points represent genes with a P < 0.05 and a log2 fold change >1.25, and yellow points represent genes with a P < 0.05 and a log2 fold change > 1.5. (E) Top 20 gene ontology terms enriched within the significantly differentially expressed genes between the Notch1.129S+/– vs. WT proximal aortas. Terms were identified through analysis with the Database for Annotation, Innovation and Integrated Discovery (DAVID). Green bars represent GO-FAT biological processes, pink bars represent GO-FAT cellular component, and blue bars represent GO-FAT molecular function.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts